Skip to content

BillionToOne, Inc. BLLN Finance Lease Liability - Undiscounted Excess Amount

Finance Lease Liability - Undiscounted Excess Amount at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$4.84B
Enterprise value$4.44B
P/E163.1×
P/S13.6×

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Return on equity23.5%
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount.

The official record: BillionToOne, Inc. ’s 10-K, filed March 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's finance lease liability - undiscounted excess amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's finance lease liability - undiscounted excess amount?
BillionToOne, Inc. (BLLN) reported finance lease liability - undiscounted excess amount of $38K in Q4 2025.
What does finance lease liability - undiscounted excess amount mean?
This represents the total undiscounted future cash payments required for finance leases, excluding the recognized lease liability. It provides visibility into the long-term contractual obligations for leased assets that are not yet reflected as current debt. Monitoring this helps investors understand the full scale of off-balance sheet or future lease commitments.